C4 Therapeutics, Inc. (CCCC)
3.10
+0.15
(+5.08%)
USD |
NASDAQ |
Nov 06, 16:00
3.09
-0.01
(-0.32%)
After-Hours: 20:00
C4 Therapeutics Gross Profit Margin (Quarterly) : 78.90% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 78.90% |
| June 30, 2026 | 73.05% |
| March 31, 2026 | 70.72% |
| December 31, 2025 | 83.61% |
| September 30, 2025 | 81.55% |
| June 30, 2025 | 67.75% |
| March 31, 2025 | 72.19% |
| December 31, 2024 | 65.89% |
| September 30, 2024 | 86.62% |
| June 30, 2024 | 82.97% |
| March 31, 2024 | 33.30% |
| December 31, 2023 | 48.14% |
| September 30, 2023 | 81.98% |
| June 30, 2023 | 25.34% |
| March 31, 2023 | 45.14% |
| Date | Value |
|---|---|
| December 31, 2022 | 29.12% |
| September 30, 2022 | 71.59% |
| June 30, 2022 | 84.52% |
| March 31, 2022 | 80.55% |
| December 31, 2021 | 96.22% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.64% |
| Return on Assets | -27.48% |
| Return on Invested Capital | -32.24% |
| Profit Margin (Quarterly) | -257.9% |
| Operating Margin (Quarterly) | -290.5% |
| Return on Net Operating Assets | -196.1% |